| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 248.431 | 206.578 | 183.098 | 142.300 | 147.026 | 140.680 | 159.438 | 185.125 | 177.089 | 194.634 |
| Total Income - EUR | 248.431 | 206.552 | 183.083 | 142.092 | 157.562 | 182.588 | 187.739 | 185.125 | 182.547 | 208.728 |
| Total Expenses - EUR | 246.070 | 213.599 | 194.085 | 142.337 | 153.431 | 151.398 | 166.037 | 186.760 | 184.388 | 209.849 |
| Gross Profit/Loss - EUR | 2.361 | -7.048 | -11.002 | -245 | 4.132 | 31.190 | 21.702 | -1.635 | -1.841 | -1.122 |
| Net Profit/Loss - EUR | 2.361 | -7.048 | -12.663 | -1.662 | 2.558 | 29.950 | 20.044 | -3.010 | -3.666 | -2.640 |
| Employees | 9 | 8 | 7 | 0 | 5 | 5 | 5 | 3 | 5 | 6 |
Check the financial reports for the company - Cera Pharm Life Vp Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 93.375 | 74.504 | 75.261 | 69.875 | 55.446 | 56.686 | 42.427 | 10.138 | 12.721 | 13.978 |
| Inventories | 80.024 | 68.193 | 59.875 | 59.432 | 52.963 | 50.052 | 39.785 | 6.335 | 9.703 | 6.601 |
| Receivables | 1.246 | 1.487 | 481 | 1.601 | 1.573 | 759 | 1.978 | 2.668 | 1.788 | 4.370 |
| Cash | 12.105 | 4.823 | 14.906 | 8.841 | 911 | 5.875 | 664 | 1.135 | 1.230 | 3.008 |
| Shareholders Funds | -31.838 | -38.561 | -50.572 | -51.315 | -47.764 | -16.908 | 3.511 | 512 | -3.156 | -5.779 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 125.213 | 113.065 | 125.833 | 121.190 | 103.210 | 73.594 | 38.916 | 9.626 | 15.877 | 19.757 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8699 - 8699" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Cera Pharm Life Vp Srl